does tirzepatide cause kidney damage Interplay of Chronic Disease and the Effects of in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity: The SUMMIT Trial Tirzepatide and Kidney Health: Safety

Through precise dose optimization, gradual titration, and individualized management, it has demonstrated superior outcomes in both obesity and type 2 diabetes populations

If you are interested in learning more about Semaglutide or Tirzepatide, and would like to set up a consultation with one of our wellness and medical weight loss experts, give us a call at 561-918-3963

Pediatrics 151(2):e2022060640 Singhal V, Sella AC, Malhotra S (2021) Pharmacotherapy in pediatric obesity: current evidence and landscape

Neuroprotection: Benefits for your brain Several studies have shown that people using GLP-1 receptor agonists like semaglutide have a significantly lower risk of developing Alzheimer's disease, Parkinson's disease, Lewy body dementia, and vascular dementia

The medication's primary benefit in this population is weight loss through appetite suppression rather than direct glucose-lowering effects

Kirby, M.D., Ph.D., associate professor in the Division of Endocrinology and Metabolism at the University of Virginia Health System